Company profile: Argos Therapeutics
1.1 - Company Overview
Company description
- Provider of immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. Conducts clinical trial programs in cancer and HIV. Product candidates include AGS-0031 for metastatic renal cell carcinoma, AGS-0041 for HIV, and CD83.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Argos Therapeutics
Cullinan Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage oncology therapeutics, including zipalertinib (CLN-081/TAS6417) for NSCLC with EGFR exon 20 insertion mutations in pivotal Phase 2b; CLN-619, an anti-MICA/B antibody tested with a checkpoint inhibitor for advanced solid tumors and multiple myeloma; CLN-049 for relapsed/refractory AML and MDS in Phase 1; and CLN-617, a collagen-binding IL-12/IL-2 fusion for advanced solid tumors, both as monotherapy and in combination with pembrolizumab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cullinan Therapeutics company profile →
Sofie
HQ: United States
Website
- Description: Provider of molecular imaging, focused on empowering people with new PET technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sofie company profile →
SonoCiné
HQ: United States
Website
- Description: Provider of an imaging solution for breast cancer screening, which the company develops and markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SonoCiné company profile →
YM BioSciences
HQ: Canada
Website
- Description: Provider of life sciences product development services focused on identifying and advancing a diverse portfolio of cancer-related products at various stages of development, leveraging regulatory and clinical trial expertise and a diversified business model to reduce risk while advancing clinical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full YM BioSciences company profile →
Dren Bio
HQ: United States
Website
- Description: Provider of protein engineering technologies for depleting cells, protein aggregates, and other disease-causing agents. Develops antibody therapeutics including DR-01, a fully human, nonfucosylated ADCC-inducing antibody for hematologic malignancies and autoimmune disorders, and a Targeted Myeloid Engager and Phagocytosis Platform with DR-0201 for B cell malignancies and DR-0202 for solid tumors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dren Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Argos Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Argos Therapeutics
2.2 - Growth funds investing in similar companies to Argos Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Argos Therapeutics
4.2 - Public trading comparable groups for Argos Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →